NEWS
RIC group has renewed its CIR (Credit d’Impôt Recherche) certificate until 2023
RIC group has renewed its CIR (Credit d'Impôt Recherche) certificate until 2023 The research tax credit (CIR) is a tax system to support the research and development (R&D) activities [...]
ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic
ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic ONA Therapeutics, Absolute Antibody and RIC - three leading European companies in the biotech landscape [...]
Host cell protein monitoring using micro-pillar array columns & mass spectrometry
Host cell protein monitoring using micro-pillar array columns & mass spectrometry Protein biopharmaceuticals are typically recombinantly manufactured in mammalian, yeast or bacterial [...]
Multidimensional liquid chromatography for your biologics
Multidimensional liquid chromatography for your biologics Biopharmaceutical analysis typically involves a wide range of analytical techniques and methodologies to determine different stru [...]
Expanding the analytical portfolio for biopharmaceuticals
Expanding the analytical portfolio for biopharmaceuticals Biopharmaceuticals are becoming a core aspect of the pharmaceutical industry. These recombinantly produced therapeutic macromolec [...]
New innovation project takes off at RIC
New innovation project takes off at RIC We are happy to announce that we have received approval for a Baekeland mandate to kick off a new innovation initiative at our facilities. This pro [...]
